SEC Form 4 · accession 0001179110-16-025561
INTERMOLECULAR INC · IMI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Kenneth H Traub
Director · Other
Period of report
May 25, 2016
Accepted (ET)
May 26, 2016 · 4:35 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001311241
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $1.85 | May 25, 2016 | A | 75,000 | A | — | May 24, 2026 | Common Stock | 75,000 | 75,000 | D |
Explanation of responses
- F1The option vests in four equal annual installments beginning on the first anniversary of the grant date, subject to continued service.
Remarks
1. The Reporting Person may be deemed to be a member of a Section 13(d) group that may be deemed to collectively beneficially own more than 10% of the Issuer's outstanding shares of Common Stock.